Physicians “Cautiously Open” To OTC Statins – NLA Survey
This article was originally published in The Tan Sheet
Executive Summary
More than half the physician respondents in a National Lipid Association survey said it is "important" that FDA look into the potential of an OTC statin for patients at moderate risk for coronary heart disease